论文部分内容阅读
长期以来,免疫学家们梦想根据选择的特定抗原、生产大量纯抗体。这种特定抗原可能存在于致病性毒病或癌细胞表面。正是由于杂交瘤(Hybridoma)技术的成功,使这一梦想变为现实。
For a long time, immunologists have dreamed of producing large amounts of pure antibodies based on the specific antigen of choice. This particular antigen may be present on pathogenic toxicants or on the surface of cancer cells. It is because of the success of hybridoma technology that makes this dream a reality.